Squadron Capital Management LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

Filing Manager
Squadron Capital Management LLC
Reporting Manager
Squadron Master Fund LP
Security
Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share
Symbol
KTTA
Shares outstanding
23,532,818 shares
Disclosed Ownership
2,329,749 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 11:36:30 UTC
Date of event
31 Dec 2025
Previous filing
05 Dec 2025
SEC
View on sec.gov

Key filing fact

Squadron Capital Management LLC disclosed 9.9% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 31 Dec 2025.

Key facts

  • Squadron Capital Management LLC filed SCHEDULE 13G/A for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
  • Disclosed ownership: 9.9%.
  • Date of event: 31 Dec 2025.

Change

  • Previous schedule filing date: 05 Dec 2025.
  • Current filing was accepted on 17 Feb 2026, 11:36.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Squadron Master Fund LP 9.9% 2,329,749 0 2,329,749 /s/ Matthew Sesterhenn Partner, Squadron Partners LLC, its General Partner
Squadron Capital Management LLC 9.9% 2,329,749 0 2,329,749 /s/ Matthew Sesterhenn Partner
Matthew Sesterhenn 9.9% 2,329,749 0 2,329,749 /s/ Matthew Sesterhenn Matthew Sesterhenn
William Blank 9.9% 2,329,749 0 2,329,749 /s/ William Blank William Blank
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .